This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignees: Impact Therapeutics, Inc., Other. Active years: 2015-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 11 
1 out of 834,601 Years Active: 2015-2022
Title: Lijun Liu: Innovator in Pharmaceutical Chemistry
Introduction
Lijun Liu is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 5 patents, Liu's work has garnered attention in the scientific community.
Latest Patents
One of Liu's latest patents is focused on 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors. This patent discloses the use of these compounds, represented by the Formula (I), for their potential therapeutic benefits. The innovative approach taken by Liu in this area highlights his commitment to advancing medical science.
Career Highlights
Throughout his career, Lijun Liu has worked with various organizations, including Impact Therapeutics, Inc. His experience in the pharmaceutical industry has allowed him to develop and refine his inventions, contributing to advancements in drug development.
Collaborations
Liu has collaborated with notable colleagues, including Ye Edward Tian and Lizhen Wu. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Lijun Liu's contributions to pharmaceutical chemistry and his innovative patents demonstrate his dedication to improving healthcare through scientific research. His work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile